Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$328M |
| 2 |
Johnson & Johnson
JNJ
|
+$229M |
| 3 |
GE Aerospace
GE
|
+$156M |
| 4 |
Target
TGT
|
+$155M |
| 5 |
Walt Disney
DIS
|
+$153M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$283M |
| 2 |
Eli Lilly
LLY
|
+$211M |
| 3 |
Microsoft
MSFT
|
+$199M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$184M |
| 5 |
Citigroup
C
|
+$177M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.03% |
| 2 | Healthcare | 12.1% |
| 3 | Consumer Discretionary | 11.99% |
| 4 | Consumer Staples | 11.92% |
| 5 | Industrials | 10.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NXTM
2051
DELISTED
NxStage Medical Inc.
NXTM
| $916K | ﹤0.01% |
69,600
-62,700
| -47% | -$822K |
|
2052
Ameris Bancorp
ABCB
$6B
| $915K | ﹤0.01% |
49,800
+11,700
| +31% | +$221K |
|
2053
Acme United Corp
ACU
$228M
| $913K | ﹤0.01% |
60,500
+3,000
| +5% | +$41.6K |
|
2054
China Yuchai International
CYD
$1.76B
| $911K | ﹤0.01% |
+38,314
| New | +$748K |
|
|
ANCX
2055
DELISTED
Access National Corp
ANCX
| $911K | ﹤0.01% |
63,900
-16,300
| -20% | -$238K |
|
|
AFSI
2056
DELISTED
AmTrust Financial Services, Inc.
AFSI
| $909K | ﹤0.01% |
46,612
-113,460
| -71% | -$2.11M |
|
2057
UTStarcom
UTSI
$23M
| $907K | ﹤0.01% |
82,474
+2,050
| +3% | +$22K |
|
2058
Clearwater Paper
CLW
$356M
| $898K | ﹤0.01% |
+18,800
| New | +$912K |
|
|
TULP
2059
Bloomia Holdings
TULP
$17.2M
| $897K | ﹤0.01% |
47,957
+7,028
| +17% | +$122K |
|
|
INWK
2060
DELISTED
InnerWorkings, Inc.
INWK
| $897K | ﹤0.01% |
+91,312
| New | +$999K |
|
|
CCIH
2061
DELISTED
Chinacache International Holdings Ltd
CCIH
| $897K | ﹤0.01% |
150,800
-11,500
| -7% | -$54.7K |
|
2062
Peapack-Gladstone Financial
PGC
$822M
| $894K | ﹤0.01% |
48,197
+12,597
| +35% | +$226K |
|
|
NOVB
2063
DELISTED
NORTH VALLEY BANCORP-COM
NOVB
| $892K | ﹤0.01% |
47,180
+19,400
| +70% | +$350K |
|
2064
E.W. Scripps
SSP
$310M
| $890K | ﹤0.01% |
54,660
-344,974
| -86% | -$4.97M |
|
2065
W.P. Carey
WPC
$16.1B
| $884K | ﹤0.01% |
13,950
-235,582
| -94% | -$15.5M |
|
2066
Crown Crafts
CRWS
$32M
| $881K | ﹤0.01% |
122,100
+17,817
| +17% | +$122K |
|
|
RELV
2067
DELISTED
Reliv International Inc
RELV
| $874K | ﹤0.01% |
47,671
+871
| +2% | +$13.2K |
|
2068
Flexsteel Industries
FLXS
$301M
| $869K | ﹤0.01% |
34,800
+15,500
| +80% | +$375K |
|
|
ASFI
2069
DELISTED
Asta Funding Inc
ASFI
| $869K | ﹤0.01% |
97,800
-5,200
| -5% | -$45.4K |
|
|
MERU
2070
DELISTED
MERU NETWORKS INC COM STK (DE)
MERU
| $869K | ﹤0.01% |
265,600
-1,100
| -0.4% | -$4.28K |
|
2071
MACOM Technology Solutions
MTSI
$23.5B
| $865K | ﹤0.01% |
50,800
+21,300
| +72% | +$338K |
|
|
NW.PRC.CL
2072
DELISTED
Natwest Bank Ads Series C
NW.PRC.CL
| $865K | ﹤0.01% |
34,525
+8,854
| +34% | +$222K |
|
|
CLVS
2073
DELISTED
Clovis Oncology, Inc.
CLVS
| $863K | ﹤0.01% |
14,200
-7,200
| -34% | -$511K |
|
2074
Veeco
VECO
$3.26B
| $862K | ﹤0.01% |
+23,160
| New | +$810K |
|
2075
TAT Technologies
TATT
$508M
| $857K | ﹤0.01% |
106,600
+3,200
| +3% | +$23.2K |
|
Similar funds
Jim Simons's Q3 2013 Portfolio in Review
As of Q3 2013, Jim Simons held 3,196 positions worth $41.2B, up 8.1% from $38.1B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons's Q3 2013 filing shows 439 new, 1,284 increased, 1,031 reduced and 412 closed positions. Its largest new stake was GE Aerospace: 1,361,721 shares worth $156M. The largest sale was Apple, an estimated $283M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q3 2013 buy was GE Aerospace: 1,361,721 shares worth $156M.
- Jim Simons added most to IBM in Q3 2013, an estimated $328M increase.
- Jim Simons's biggest Q3 2013 reduction was Eli Lilly, cutting an estimated $211M.
- Jim Simons fully exited Apple in Q3 2013, selling an estimated $283M.
- Jim Simons's ten largest holdings make up 11% of its $41.2B portfolio in Q3 2013.
- Jim Simons opened 439 new positions and closed 412 in Q3 2013.
- Jim Simons's portfolio value rose 8.1% quarter-over-quarter to $41.2B.
Based on Renaissance Technologies's 13F filing for Q3 2013, filed 13 Nov 2013.